Related Experiment Video
Updated: Jan 15, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases
Anahi V Odell1,2, Nathan M Newton1,2,3, Anna Eisenstein1
1Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Abstract:
Chronic inflammatory skin diseases affect the health of millions of people worldwide, and those that feature fibrosis are refractory to treatments. The signals that determine whether fibrosis occurs during chronic skin inflammation are poorly understood. We generated a scRNA-seq atlas of seven inflammatory skin diseases and their healthy controls. Diseases with fibrosis demonstrate higher expression and activity of STAT1 in fibroblasts. Fibroblast STAT1 is required for skin fibrosis development in mice. STAT1 activation promotes a fibrotic gene expression profile which can be activated directly by EGFR in a JAK-independent manner and abrogated by genetic and pharmacologic STAT1 inhibition. The EGFR-STAT1 pathway is stimulated by high affinity EGFR ligands expressed by activated keratinocytes, suggesting keratinocyte-derived signals as triggers of skin fibrosis. In sum, fibroinflammatory skin diseases are characterized by fibroblast EGFR-STAT1 signaling that controls expression of fibrotic genes, elucidating an interferon independent function of STAT1 to mediate fibrotic skin diseases.
Insights
Fibroblast STAT1 signaling, driven by EGFR, is crucial for skin fibrosis in chronic inflammatory skin diseases. Inhibiting this pathway offers a potential therapeutic strategy for these difficult-to-treat conditions.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- Chronic inflammatory skin diseases, particularly those involving fibrosis, present significant therapeutic challenges.
- The molecular signals dictating fibrotic progression in skin inflammation remain largely unelucidated.
Purpose of the Study:
- To investigate the molecular mechanisms underlying fibrosis in chronic inflammatory skin diseases.
- To identify key signaling pathways and cellular components involved in fibrotic skin disease pathogenesis.
Main Methods:
- Generation of a single-cell RNA sequencing (scRNA-seq) atlas comparing seven inflammatory skin diseases with healthy controls.
- In vivo studies using mouse models to assess the role of fibroblast STAT1 in skin fibrosis.
- Investigating the interplay between EGFR, STAT1, and fibrotic gene expression.
Main Results:
- Fibrotic skin diseases exhibit elevated STAT1 expression and activity in fibroblasts.
- Fibroblast-specific STAT1 is essential for the development of skin fibrosis in mice.
- EGFR directly activates STAT1 in a JAK-independent manner, promoting a fibrotic gene expression profile.
- Keratinocyte-derived EGFR ligands stimulate the EGFR-STAT1 pathway, suggesting a role in initiating fibrosis.
Conclusions:
- The EGFR-STAT1 signaling axis in fibroblasts is a key mediator of fibrotic gene expression in fibroinflammatory skin diseases.
- This study reveals an interferon-independent function of STAT1 in driving fibrotic skin conditions.
- Targeting the EGFR-STAT1 pathway presents a potential therapeutic avenue for refractory fibrotic skin diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
TGF - β Signaling Pathway
MAPK Signaling Cascades
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Introduction to Fibroblasts

